• Vivesto appoints Björn Svanström as CFO

    June 5, 2026

    Read more

  • Vivesto reports positive results from i.v. Cantrixil PK/toxicology study

    June 16, 2026

    Read more

  • Vivesto completes recruitment in Paccal Vet dog pilot study – topline results expected Q3 2026

    June 26, 2026

    Read more

Liberi Group -A Proven Partner in Life Science Business Development

Read the interview

CEO corner

Learn more (in Swedish)

Press releases

All press releases

Interim Report Q1 2026 (In Swedish)

Vivesto published its interim report for Q1 2026 on May 7, 2026, at 08.00 am CEST.

Read the report (in Swedish)

Calendar

All events

The Share

Follow the share
Visit our Investor section

Annual Report 2024

Read the report